CURALEAF, the US cannabis giant now valued at over $8bn, has officially completed its integration of EMMAC Life Sciences in
FOLLOWING its recent purchase of UK cannabis firm EMMAC Life Sciences, Curaleaf has now secured an additional $130m from a
EMMAC CEO Antonio Costanzo believes its purchase by US and global leader Curaleaf is a signal to Europe’s politicians that
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
